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Abstract
Background: An important issue in the target identification for the drug design is the tissue-specific effect of
inhibition of target genes. The task of assessing the tissue-specific effect in suppressing gene activity is especially
relevant in the studies of the brain, because a significant variability in gene expression levels among different areas
of the brain was well documented.
Results: A method is proposed for constructing statistical models to predict the potential effect of the knockout of
target genes on the expression of genes involved in the regulation of apoptosis in various brain regions. The model
connects the expression of the objective group of genes with expression of the target gene by means of machine
learning models trained on available expression data. Information about the interactions between target and
objective genes is determined by reconstruction of target-centric gene network. STRING and ANDSystem databases
are used for the reconstruction of gene networks. The developed models have been used to analyse gene knockout
effects of more than 7,500 target genes on the expression of 1,900 objective genes associated with the Gene
Ontology category “apoptotic process”. The tissue-specific effect was calculated for 12 main anatomical structures of
the human brain. Initial values of gene expression in these anatomical structures were taken from the Allen Brain
Atlas database. The results of the predictions of the effect of suppressing the activity of target genes on apoptosis,
calculated on average for all brain structures, were in good agreement with experimental data on siRNA-inhibition.
Conclusions: This theoretical paper presents an approach that can be used to assess tissue-specific gene knockout
effect on gene expression of the studied biological process in various structures of the brain. Genes that, according
to the predictions of the model, have the highest values of tissue-specific effects on the apoptosis network can be
considered as potential pharmacological targets for the development of drugs that would potentially have strong
effect on the specific area of the brain and a much weaker effect on other brain structures. Further experiments
should be provided in order to confirm the potential findings of the method.
Background
At present time of intensive investigations of the gen-
omes of various organisms, the task of identifying func-
tional relationships between genes and molecular
mechanisms of reaction of the organisms to the impact
of external and internal factors becomes the most cru-
cial issue. The analysis of transcriptome data (RNASeq,
microarray expression analysis, real-time PCR, etc.) often
serves as the main experimental method to establish the
effect of different perturbations on gene expression.
Among the most commonly used databases containing
information about the level of gene expression in differ-
ent tissues of human and model animals we can mention
Allen Brain Atlas [1], GENSAT (Gene Expression Ner-
vous System Atlas) [2], BGEM (Brain Gene Expression
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Map) [3] and GEO (Gene Expression Omnibus) [4].
Particular attention should be given to the Allen Brain
Atlas (ABA) database, which provides detailed data on
gene expression in various tissues of the human and
mouse brain, distributed over voxels or extended regions.
Predictions of the effects of various factors on gene
expression are usually performed by means of mathema-
tical models. There are well-developed approaches to
modelling the functioning of molecular genetic systems
and gene networks, for example, kinetic modelling [5-7].
These models require information about the interaction
parameters and reaction rates, the number of which is
growing rapidly with an increase in gene network size.
It should be noted that the quantitative information
about the reaction rates is absent for most genes and
for their products involved in the reactions. One of the
most interesting areas of molecular-genetic interactions
is genetic regulation. In connection with this, a large
number of works presented in the literature are devoted
to the study of the quantitative characteristics of genetic
regulation using expression data [5,8-16]
In order to evaluate the kinetic parameters of genetic
regulation, the main source of data are time-series mea-
surements of gene expression, including RNA and pro-
tein concentrations [10-13]. However, obtaining the data
on the dynamics of expression, which can be used to
develop mathematical models to describe the functioning
of various molecular-genetic systems is often complicated
due to the methodological difficulties and high costs [12].
For this reason, when creating the mathematical models,
researchers are usually faced with the inverse problem
when the number of samples or dimensions in the data is
smaller than the number of parameters (so-called ill-
posed inverse problem). Another problem should be also
highlighted that occurs when one tries to create a mathe-
matical model that describes the actual biological pro-
cesses, distributed among different tissues and organs of
a body. This is a classical problem of heterogeneity of the
modelled objects. In particular, the spatial heterogeneity
of the gene expression in the brain is observed in the
analysis of expression data from the database Allen Brain
Atlas.
An alternative to using the kinetic data would be to
use information about the steady-state expression levels
obtained under different conditions or in different tis-
sues [14-16]. Such type of data is more widely available
in databases compared to the kinetic data and allows
researchers to compute the results in terms of tissue- or
condition-specific effects.
Approaches that use these data to reconstruct the net-
work of genetic regulation and to define its parameters
include approaches that use Bayesian networks [17-20]
and ones based on mutual information [21,22]. Those
are well-designed techniques that can identify regulatory
interactions from expression data. Although these meth-
ods make it possible to generate semi-quantitative pre-
dictions, e.g. direction and relative magnitude of
regulatory influences, it is difficult to obtain quantitative
predictions based on models reconstructed using these
methods.
Another example would be the use of machine learn-
ing techniques, including regression models, neural net-
works, support vector machines and others. Models
built using these techniques allow quantitative predic-
tions of the expression levels of the specific genes con-
sidering the expression levels of genes interacting with
these specific genes.
However, the problem of dimensionality or complete-
ness of the data remains in this case as well. Therefore,
a number of approaches are being used to reduce the
dimensionality of the model that reconstructs molecular
genetic interactions from expression data. One of the
approaches is to limit the number of interactions for a
given gene [5,8]. Another approach to the reduction of
the number of genes being analysed is to combine genes
into groups based on their expression profiles in order
to examine the so-called co-regulated gene modules
[14,23,24]. Yet another approach is to consider only
known transcription factors as independent variables in
the regression equation [8,14,24].
The aim of this work was to construct a statistical
model describing the potential knockout effect of target
genes on the expression of genes involved in the regula-
tion of apoptosis in various areas of the human brain.
Evaluation of tissue-specific effects of a particular gene
knockout on apoptosis, or programmed cell death, is a
very challenging and very important question in modern
pharmacology, medical systems biology and biomedicine.
It is known that apoptosis plays an important role in
various biological processes including functioning of the
immune system, normal cell turnover, embryonic devel-
opment and others [25]. Neuronal apoptosis in the
embryonic brain is significant for normal development
and functioning of nervous system. Disruptions in apop-
tosis during embryonic development may lead to brain
neuroanatomic abnormalities [26]. Moreover, dysregula-
tion of apoptotic pathways can lead to development of
pathological conditions in brain such as cancers, ischemic
and autoimmune abnormalities, and neurodegenerative
disorders, including Alzheimer’s and Parkinson’s diseases
[25,27,28]. Better understanding of the molecular-genetic
mechanisms involved in apoptosis regulation in the brain
can help in the identification of new potential therapeutic
targets for drugs against such serious diseases as cancers,
Alzheimer’s and Parkinson’s diseases.
Using STRING [29] and ANDSystem [30] databases we
reconstructed target-centric gene networks associated
with genes involved in the «apoptotic process» Gene
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Ontology (GO) [31,32] category. Gene Ontology Annota-
tions [31] is a constantly updated database that contains
a structured, precisely defined, controlled vocabulary for
describing the roles of genes and gene products in biolo-
gical processes. Database of Gene Ontology Annotations
is one of the most comprehensive sources of information
on the relationship of genes / proteins with different
biological processes, for example, about 2 thousands of
genes / proteins are involved in the GO category «apop-
totic process» and 213 children GO categories, associated
with apoptosis. For comparison, the KEGG database
includes information about 85 genes / proteins that are
involved in apoptosis. Of these, 56 genes (66%) are on
the list of genes associated with apoptosis according to
Gene Ontology Annotations.
STRING is one of the most widely used resources in
the reconstruction of molecular genetic networks.
STRING database describes different types of relation-
ships between genes, including protein-protein interac-
tions, associations, etc., however, the genetic regulation is
not explicitly presented. Therefore, in addition to the
reconstruction of gene regulatory networks, we used a
system developed earlier called ANDSystem, containing
information about interactions between genes, proteins,
metabolites, biological processes and diseases that is
automatically extracted from scientific publications.
Interactions between molecular genetic entities in
ANDSystem are classified into more than 20 different
types of interactions, which includes both positive and
negative regulation of the gene expression by products of
other genes, as well as regulation of unknown sign. Using
information about the direct and indirect relationships
between genes in the reconstructed gene network has
allowed us to significantly reduce the dimensionality of
the model, providing an opportunity to train the model
on the available experimental data. Our study examined
12 major anatomical structures of the brain, as well as
1,900 genes related to apoptosis (objective genes) accord-
ing to the Gene Ontology Annotations [31] database, and
more than 7,500 target genes, for which we found a link
to one or more of objective genes and analysed their cor-
responding knockout effect in our model. It turned out
that among the examined target genes some showed a
pronounced structure-specific effect of their knockout on
the expression of objective genes in distinct anatomical
structures of the brain according to created models. The
analysed target genes included the genes directly involved
in the «apoptotic process» Gene Ontology biological pro-
cess. But a significant number of target genes were also
presented by new potential pharmacological targets that
are not included in the list of the apoptosis genes.
Gene Ontology enrichment analysis was conducted on
a set of target genes with the highest values of calcu-
lated knockout effects on the apoptosis network and
additionally showed the importance of several Gene
Ontology categories, such as the regulation of metabolic
processes, cell proliferation and cell death, immune pro-
cesses, response to various stimuli and stress.
Genes, expression downregulation of which has a pre-
dicted effect on apoptosis, can be considered as potential
pharmacological targets. In this regard, it was important
to analyse the distribution of known drug targets among
genes with the highest predicted knockout effect values
on the apoptosis network in different regions of the brain
corresponding to distinct anatomical structures. The ana-
lysis showed that among the potential target genes that
have the strongest effect on apoptosis, there are a num-
ber of known pharmacological targets. In particular, the
percentage of known targets was increasing with the cal-
culated knockout effect value. Interestingly, among the
known pharmacological targets the genes were identified
that were known targets for drugs against cancer and
immune system diseases.
Comparison of the predictions of target genes knock-
out effect on apoptosis with the experimental data on
siRNA-inhibition [33,34] showed good agreement
between the theoretical and experimental data. Genes
with experimentally confirmed connection between their
expression suppression and caspase 3 activation, as well
as genes that significantly induced cell death upon their
downregulation in T98G glioblastoma-derived cell line,
had significantly higher knockout effect calculated using
our models compared to average effect among analysed
target genes.
Thus, the developed method can be used in evaluating
the effect of inhibition of specific genes on the function
of the specific biological processes in different tissues and
structures of the brain. The obtained results of target
genes knockout effect considering their spatial distribu-
tion among brain structures on the programmed cell
death, can serve as the basis for the search for pharmaco-
logical targets with enhanced effects in the specifically
selected brain areas.
Methods
For creating statistical models, we used expression data
available from the Allen Brain Atlas. Those data were
used as “initial” experimental values. The data contained
whole-genome normalized microarray expression data
for different anatomical areas of adult human brain.
Allen Brain Atlas contained human brain expression data
for six different donors with data on various brain areas
for different donors. All donors were with no known neu-
ropsychiatric or neuropathological history, no history of
long-lasting hypoxic conditions, and no infectious dis-
eases found by a serology screen. Detailed data acquisi-
tion and normalization procedures are described in [35].
Brief analysis showed that whole brain average gene
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expression values were highly correlated between donors
(Pearson correlation coefficient >0.95), therefore it was
decided to use data for H0351.2002 donor, which con-
tained information on the largest number of different
areas of the brain (893).
Allen Brain Atlas data included repeated measurements
for a number of genes and brain regions, and for each
region of the brain its spatial coordinates on the MRI
image were included. Those coordinates were further
used when presenting images of spatial distribution of
calculated values in the brain. For each brain area the
Allen Brain Atlas also provided corresponding anatomi-
cal brain structure. This information was used to predict
the effect of a knockout of target genes on the expression
of objective genes in given brain structures. During the
preliminary processing the repeated measurements were
averaged and the resulting normalized data for expres-
sion levels of 18,242 genes in 893 spatial areas of the
brain were obtained.
When constructing the models we used the genes
involved in «apoptotic process» GO category and all its
children GO categories as genes of interest (further,
objective genes), i.e. we modelled effect of gene knock-
outs on expression of those genes only. All the genes
interacting with the objective genes were analysed as
potential knockout targets (further, target genes). To
build gene networks that describe direct and indirect
interactions between target and objective human genes
we used STRING [29] and ANDSystem [30]. STRING is
a well-known database of interactions between genes/
proteins accumulating a large number of information
sources, including factual and supervised databases. In
the STRING database each link between genes is
described with a combined weight (combined score),
which is a parameter that determines the statistical sig-
nificance of relationships. In this paper, the threshold for
the combined weight was chosen as 0.9, corresponding to
the highest degree of reliability (highest confidence, as
described in STRING database). ANDSystem was pre-
viously developed for the automatic extraction of knowl-
edge about molecular-genetic interactions between
proteins, genes, metabolites, biological processes and dis-
eases from the texts of scientific publications and their
presentation in the form of associative semantic net-
works. All interactions in ANDSystem are divided into
more than 20 categories. Unlike STRING database the
ANDSystem explicitly describes interactions related to
gene regulation, including positive and negative regula-
tion of gene expression. In this regard, ANDSystem was
used to reconstruct gene regulatory networks which
included only interactions corresponding to gene expres-
sion regulation.
Gene Ontology biological processes enrichment analy-
sis was performed using the BiNGO plugin of Cytoscape
system [36,37]. Benjamini & Hochberg False Discovery
Rate (FDR) correction was used. In addition to standard
enrichment analysis we also performed an analysis of
functional connectivity of target genes considered in the
enrichment analysis. We assume that the connectivity of
genes involved in a common biological process exceed
the connectivity between randomly selected genes.
Earlier, we used the approach in the analysis of molecu-
lar association of pathogenetic contributors to pre-
eclampsia [38], as well as in the analysis of molecular
genetic mechanisms of dystropy [39]. It was shown that
functionally connected genes have more connections
between each other than randomly selected genes.
Therefore, evaluation of the functional connectivity
between genes that determine overrepresented GO pro-
cesses can be used to detect GO processes most closely
associated with the analysed set of genes.
To assess the functional connectivity of a set of target
genes involved in a given overrepresented GO category
we compared the gene network with these genes as ver-
tices with networks built on random sets of genes. For
each overrepresented GO category we automatically cre-
ated 1,000 gene networks with random sets of genes
using ANDSystem. Random sets of genes were chosen to
be of the same length and having the same node degree
distribution as the set of analysed target genes from the
GO category thus ensuring the adequacy of further com-
parison. For each analysed target gene we formed the
restricted list consisting of genes with the same vertex
degree as for target gene. To avoid a connectivity bias
related to the possible presence of target vertices with
high degrees in contrast with random vertices we
restricted the list of genes from which we randomly take
a vertex. Then, we randomly took a vertex from this list
to reconstruct a semi-random network. After the recon-
struction of the networks the distribution of the number
of links was built for the semi-random networks. As the
characteristic of functional connectivity between genes in
the gene network constructed by genes directly involved
in the GO category, we considered the frequency of
observing the semi-random networks with equal or
greater number of connections. This approach assumes
that functionally related genes have a greater number of
interactions with each other than genes from a random
set. Calculated in this way the measure of functional con-
nectivity was used to rearrange the significantly overre-
presented GO biological processes.
Visualization of the spatial distributions of the
obtained values for each spatial area was performed
using the nilearn [40] library of the sci-kit learn [41]
Python package. The spatial coordinates of brain areas
were taken from Allen Brain Atlas database. Maximum
intensity projection (MIP) [42] method was utilized in
order to present three-dimensional distributions on
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paper. Briefly, this method presents as a 2D image a
projection of maximum intensities of the original 3D
distribution along the direction orthogonal to the image
plane.
When comparing top-100 lists of genes for different
brain structures we performed hierarchical clustering
and dendrogram visualization using linkage and dendro-
gram functions of “hierarchy” module of sci-kit learn
[41] Python package. Pairwise distances between ana-
lysed lists were calculated as a number of mismatches
between them (size of union minus size of intersection).
Information about the genes that are known pharmaco-
logical targets was extracted from DrugBank database [43].
This information was used to search for known pharmaco-
logical targets among potential target genes predicted by
the analysis of constructed models. Information about
drugs and related diseases was taken from Kyoto Encyclo-
pedia of Genes and Genomes (KEGG) [44,45].
Results and discussion
Development of target-centric statistical models
describing the effect of the inhibition of the target gene
on the network of objective genes
Creating a statistical model of the effect of inhibiting the
target gene on expression of genes from the objective
gene network encompasses two main steps. In the first
step, the target-centric gene network is reconstructed,
describing the interaction of the target gene with the
objective genes that are its immediate neighbours, and
also all direct connections of such objective genes. Let T
denote the target gene, NTj - the objective genes that
are neighbours of a target gene (j=1..mT, where mT is
the number of objective genes linked to T), and all the








A schematic representation of target-centric model is
presented on Figure 1. For example in case when con-
sidering Nod1 as a target gene the corresponding target-
centric network contained 219 nodes. The Nod1 gene
codes a cytosolic protein that recognizes bacterial mole-
cules and stimulates an immune reaction and is known
to participate in caspase-9 and NF-B activation [46,47].
For this gene mT = 6, i.e. there were 6 neighbours from
“apoptotic process” GO category (NTj ), which were
CASP1, CASP8, CASP9, CARD6, CCK and RIPK2.
Number of neighbours (N
NTj
i
) for each of them was 27,
56, 25, 3, 141 and 38, respectively. These neighbours
included the target, Nod1. Due to some amount of
intersection (i.e. some NTj had similar neighbours or
were neighbours of each other) the total number of
unique nodes in the analysed target-centric network in
this case was 219, which is less than the sum of num-
bers of neighbours, 290.
In the second step for each objective gene NTj a
regression model is built where the expression level of
the objective gene NTj serves as dependent variable, and




. To establish the connection
between the levels of expression of the objective gene
and the target gene we selected multiple linear regres-
sion analysis, as the initial stage of work had the task of
implementing and evaluating the simplest models. The






i ) + k
0
j , (1)
where Ep(NTj ) is the expression level of objective gene
NTj in brain area p, summation is over neighbours of
the objective gene NTj , Ep(N
NTj




neighbour of the objective gene NTj in brain
area p, and kij , k
0
j are the regression coefficients to be
determined from expression data for different brain
areas p.
Thus, for each target gene T we built a series of
regression models, one for each objective gene NTj
interacting with T. Each of those regression models
Figure 1 Schematic representation of the target-centric gene
network. The target gene (T) is shown with a red circle, green
circles show the objective genes NTj , which are the direct
neighbours of the target gene, blue circles denote the neighbours
of target genes N
NTj
i
. Edges denote interactions between genes.
Coverage of regression models is shown with coloured ellipses.
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described how the expression level of NTj depends on
the expression levels of N
NTj
i
genes (genes that directly
interact with NTj , including original target T). In this
case the dependency was described using linear model
with corresponding coefficients kij , k
0
j . For example, a
target-centric model for previously mentioned Nod1
gene included six regression models corresponding to
six objective genes that are neighbours of Nod1 gene in
the gene network.
As a training sample to determine the regression para-
meters we used data on spatial distribution of gene
expression levels in different parts of the human brain,
presented in the Allen Brain Atlas database. Prediction
of changes in expression levels of each of the mT objec-
tive genes after a knockout of the target gene was car-
ried out using regression models corresponding to the
objective genes. In such models, the target gene is one
of the independent variables. To simulate a knockout,
the expression level of the target gene was set to zero
and expression values of objective genes were recalcu-
lated using models from Eq. 1. In case of simulation of
the effect of activating a target gene, its expression level
values may be increased to the desired value.
The effect of the resulting target gene knockout RTp
for a given spatial area p is calculated as the sum of
moduli of relative changes in expression levels of the
objective genes for this target. The change is calculated
between the initial values of expression and the values








j ) − Ep(NTj )
Ep(NTj )
∣∣∣∣∣, (2)
where Ep(NTj ) is the initial expression value of N
T
j in
brain area p and E0p(N
T
j ) is the corresponding expres-
sion level predicted for the knockout of target gene T
and the summation is over objective genes interacting
with T.
Since the aim of this paper was to analyse changes in
the expression level of objective genes after the knock-
out of the target gene regardless of the direction of this
change, the modulus is used in the calculation of RTp .
To take into account the direction of changes in the
expression levels a different index should be used. To
assess the effect of a target gene knockout on the
expression of objective genes in a certain predetermined
brain structure s, we calculated the change in levels of
expression of the objective genes RTs , by averaging R
T
p
for all spatial points of the brain structure s.
The specificity index of the knockout effect to the








where NS is the total number of structures in the
brain, and the denominator is a sum over all the brain
structures but s. This indicator reflects the ratio of
changes in the expression levels of all objective genes in
the structure s to the changes averaged over the remain-
ing brain structures.
FCTs value clearly reflects the structure specificity of
the knockout effect of the target gene on the expression
of objective genes, but it has a drawback. FCTs may have
an extremely high value for a particular structure s, i.e.
corresponding effect demonstrates high spatial specifi-
city, when simultaneously the underlying effect can be
insignificant (low value of the RTs index).
To solve this problem, we introduced yet another indi-
cator of rank specificity (RankSpec), which is calculated
as the average ranks of a given gene in the lists of target
genes, sorted by values of FCTs and R
T
s parameters. The
same approach of average rank can be seen, for exam-
ple, in [48] and it is used to rank objects based on sev-
eral criteria simultaneously. For convenience, the range
of RankSpec values was set from 0 to 1 by normalizing
RTs and FC
T
s ranks to their corresponding maximum
values.
In addition, to estimate the average effect of a knock-
out on the whole brain without dividing it into different
anatomical structures we introduced RTall index, which
was calculated as the average value of RTp among all 893
spatial areas of the brain.
To estimate the effect of the knockouts specifically on
apoptosis, we only considered genes involved in «apop-
totic process» GO category as objective genes.
Analysis of the structure-specific knockout effect of target
genes on the expression of objective genes involved in a
GO category “apoptotic process”
List of genes involved in the «apoptotic process» GO
category included more than 1,900 human genes. Using
the STRING database we built more than 6,500 target-
centric networks in which the target gene contained at
least one neighbour from the family of the apoptotic
genes. Using the ANDSystem database more than 4,000
target-centric networks were built which included only
genetic regulation relationships as links.
Distribution of the number of connections of target
genes with objective genes is presented in Figure 2. As
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expected for the node degree distributions of biological
networks [49], it turned out to be the power-law distri-
bution. As can be seen, the maximum number of target-
centric networks contained only one objective gene
linked to the target gene. In the set of networks built
using STRING database more than 140 networks con-
tained more than 100 objective genes linked to a target
gene, whereas for ANDSystem there were only 15 such
networks.
For each target-centric network a set of objective-
centric models was constructed using multiple linear
regression analysis to predict the effect of a target gene
knockout on the expression of the objective genes and, as
a result, on the regulation of apoptosis. Training of each
model was performed on expression data for 893 spatial
areas of the brain. To investigate the spatial distribution
of the knockout effect of target genes on the expression
of objective genes, we examined the main anatomical
structures in a hierarchy represented in base Allen Brain
Atlas. A total of 12 corresponding to upper hierarchical
classification categories were selected (Table 1).
The accuracy of each objective-centric regression
model was estimated using cross-validation. Gene
expression data included in the model was randomly
divided into two subsets, one of which containing 90%
of the original spatial areas was used to train the model,
while the other (a test set containing the remaining 10%
of the points), was used to evaluate accuracy of the
model. The procedure was repeated 1,000 times, after
which the average value of the root mean square of dif-
ference between the predicted and experimental values
of gene expression of the objective gene for the spatial
points of test sample, divided by experimental values,
was calculated and used as a relative error value for the
model.
The average error of the models was 9% and 11% for
STRING and ANDSystem networks, respectively. Distri-
bution of error was asymmetric with elongated tail on
the right side. The nature of error distributions did not
significantly differ between STRING and ANDSystem
models. Higher error rates could be explained by the
possible non-linear nature of expression regulation
which could be caused by the effects of epigenetic con-
trol. Another possible reason for the errors is the
incompleteness of relationships considered in the gene
network.
To ensure the reliability of the results, models with
error rate of more than 25% were excluded from further
analysis. After exclusion, 6,133 and 3,880 target-centric
Figure 2 Distribution of the number of connections of target
genes with objective genes. Diagram presents the distribution for
objective-centric networks reconstructed using STRING (shown in
blue) and ANDSystem (shown in green) databases.
Table 1. Knockout effect values RTs of 8 top target genes on expression of objective genes involved in “apoptotic
process” GO category
Brain structures UBC * RAC1 * PTPN11 CDC42 * FYN * LAT2 CTNNB1 * GRB2
Whole brain** 105.0 / 0.95 48.4 / 0.44 31.3 / 0.28 29.3 / 0.27 27.5 / 0.25 26.5 / 0.24 26.3 / 0.24 24.3 / 0.22
Cerebellum 110.2 / 1.00 50.8 / 0.46 30.2 / 0.27 32.6 / 0.30 30.0 / 0.27 26.2 / 0.24 29.9 / 0.27 26.5 / 0.24
Pons 104.5 / 0.95 49.3 / 0.45 31.3 / 0.28 32.6 / 0.30 27.0 / 0.25 28.7 / 0.26 25.0 / 0.23 22.9 / 0.21
Thalamus 102.5 / 0.93 49.8 / 0.45 31.8 / 0.29 32.5 / 0.29 28.0 / 0.25 27.4 / 0.25 26.3 / 0.24 23.2 / 0.21
Hypothalamus 103.1 / 0.94 48.9 / 0.44 30.8 / 0.28 31.6 / 0.29 27.2 / 0.25 27.5 / 0.25 28.1 / 0.25 23.5 / 0.21
Basal ganglia 104.2 / 0.95 48.5 / 0.44 33.1 / 0.30 28.7 / 0.26 26.6 / 0.24 28.3 / 0.26 26.9 / 0.24 24.0 / 0.22
Amygdala 103.8 / 0.94 47.2 / 0.43 31.9 / 0.29 29.1 / 0.26 28.0 / 0.25 27.1 / 0.25 27.6 / 0.25 24.1 / 0.22
Hippocampus 103.8 / 0.94 51.2 / 0.46 31.8 / 0.29 31.2 / 0.28 29.3 / 0.27 26.4 / 0.24 28.3 / 0.26 25.6 / 0.23
Cingulate gyrus 105.7 / 0.96 46.9 / 0.43 30.8 / 0.28 27.2 / 0.25 27.1 / 0.25 25.1 / 0.23 24.7 / 0.22 23.9 / 0.22
Temporal lobe 105.5 / 0.96 46.7 / 0.42 30.9 / 0.28 26.6 / 0.24 26.9 / 0.24 25.2 / 0.23 24.8 / 0.23 24.6 / 0.22
Parietal lobe 105.2 / 0.95 47.0 / 0.43 31.0 / 0.28 26.7 / 0.24 26.6 / 0.24 25.2 / 0.23 24.7 / 0.22 24.3 / 0.22
Frontal lobe 106.0 / 0.96 47.3 / 0.43 30.9 / 0.28 27.0 / 0.25 26.5 / 0.24 25.5 / 0.23 24.2 / 0.22 24.4 / 0.22
Occipital lobe 105.7 / 0.96 46.9 / 0.43 31.6 / 0.29 26.2 / 0.24 26.6 / 0.24 25.2 / 0.23 24.7 / 0.22 24.6 / 0.22
Each cell contains original RTs value and R
T
s divided by maximum of R
T
s along all structures all genes, separated by a slash.
* target genes involved in “apoptotic process” GO category
** RTall
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knockout models remained for STRING and ANDSys-
tem networks, respectively. These models were used to
assess the knockout effect of target genes on the expres-
sion of objective genes. Due to the mismatch between
gene networks, the total of 7,540 different target genes
was considered.
For example, Table 1 shows the values of structure-
specific knockout effect values RTs of the top 10 target
genes for each of the 12 anatomical structures. These
genes had the strongest knockout effect on the objective
genes RTall , i.e. averaged over all 893 spatial areas of the
brain. The tabulated knockout effect values were calcu-
lated using STRING models. Interestingly all of these
genes do not show a pronounced specificity to any ana-
tomical structure. Average effects of these genes on dif-
ferent structures were approximately equal, and relative
spread of RTs values did not exceed 25%.
Target genes with the highest values of structure-spe-
cificity of the knockout effect (RankSpec) are shown in
Table 2. From the table it can be seen that the gene
NR3C1 has a maximum specificity to the cerebellum, i.e.
the suppression of its expression leads to the effect on
the expression of objective genes of “apoptotic process”
GO category which is highly specific to this structure.
NR3C1 gene encodes the glucocorticoid receptor, which
is a transcription regulator of other genes, including
those involved in the regulation of cell death and apop-
tosis [50,51]. It is known that glucocorticoid receptors
play a key role in the hypothalamic-pituitary-adrenal
(HPA) axis, which is important in the stress response
[52]. It has been shown that patients who survived early
psychosocial stress, as well as a wide range of mental
disorders, show change in the patterns of NR3C1 methy-
lation and dysregulation of HPA axis. Furthermore, in
Kitraki et al., 1999 [36] it has been shown that chronic
stress causes a down-regulation of glucocorticoid recep-
tor mRNA in cerebellum and hippocampus in rats.
Graphical representation of the distribution of the
gene knockout effect intensity among different brain
areas is shown in Figure 3. For example, it can be visua-
lized for the NR3C1 gene (Figure 3A) that its knockout
has the highest effect in the cerebellum (depicted in
red) whereas it has only marginal effects in the other
areas of the (depicted with a light-yellow colour). For
comparison the same distribution for gene Foxa2 is also
presented (Figure 3B). According to our results, this
gene has the highest RankSpec value for pons brain
structure (Table 2). The corresponding brain region is
depicted in dark-red colour on the figure which corre-
sponds to the highest values of the predicted knockout
effect. At the same type, areas of cortex and cerebellum
are depicted in light-yellow and white which corre-
sponds to the lowest predicted knockout effect on the
apoptosis-related genes in these areas. Foxa2 is a fork-
head winged helix transcription factor that is involved in
embryonic development and regulation of tissue-specific
gene expression. It was shown that Foxa2 gene plays an
important role in the apoptosis process [53,54] and is
also a gene network regulator in several types of cancer
[55,56]. Besides that, Foxa2 regulates differentiation of
dopaminergic neurons in the brain structure adjacent to
pons, the midbrain [57,58].
In order to evaluate the effect of errors in the recon-
struction of gene network on the developed method,
computer experiments were conducted with a random
mixing of up to 10% of the connections in the gene net-
work. It turned out that the noise had no significant
effect on the RTs , the value of this effect did not exceed
the noise levels in the network. The change in the index
RankSpec was bigger, but the simulated noise did not
change the lists of top genes shown in Table 2.
Table 2. Target genes with highest RankSpec values for different anatomical structures of the brain
Structure Rank 1 2 3 4 5 6 7 8 9 10
cerebellum NR3C1* PAN2 CYTSA DPYSL2 GABRB3* GABRG2 NPM1* ABL2* ACAT2 PITPNA
pons FOXA2 ESR1* PPARG* NR1D2 ESRRG NTN1* UNC5B* THRA* NR4A2* FOXO1*
thalamus DPYSL2 FOXA2 FOXO1* PITPNA CRMP1 PTGDS RORA CDK5* DPYSL4 MCAT
hypothalamus FOXA2 FOXO1* NFATC1 POMC NR2F2 NKX2-2 TBXA2R TACR2 FZD10 NTS
basal ganglia FOXO1* FOXA2 TPM1 SYN1 GAD2 MCM7 LRP6* ACTN2* MCM3 SST*
amygdala MYB NPY1R NR2F2 NPY PNOC PDYN ZNF32 ATF1 RGS7 FOXO1*
hippocampus DPYSL2 CRMP1 PRKCA* CDK5* PA2G4* DCC* NOP58 DPYSL4 ERBB2 WNT3A*
cingulate gyrus SQSTM1* AES* NEDD4L PITPNA ADCY2 SHC2 BTRC NTRK2* ZFPM1 MEF2C*
temporal lobe AES* ADCY2 SQSTM1* NEDD4L KIDINS220 STAT6 SHC2 NTRK2* MEF2C* CCK*
parietal lobe AES* STAT6 SQSTM1* ADCY2 KIDINS220 NEDD4L MEF2C* RPF1 ZFPM1 CCK*
frontal lobe SQSTM1* AES* NEDD4L ADCY2 SHC2 BTRC STAT6 MEF2C* TRAF3* ECSIT
occipital lobe AES* ERBB4* UBE2D2 MEF2C* ADRBK1 RPF1 DNM1 PTTG1 PRKCB* KIDINS220
* target genes involved in “apoptotic process” GO category
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We were interested in testing the hypothesis that the
gene knockout effect has similar character in anatomi-
cally close brain regions. To test this, we conducted a
hierarchical clustering of brain structures by comparing
the top 100 target genes in the list of target genes,
ranked by knockout effect RTs for each structure. This
clustering considered two cases, the first when the rank-
ing was conducted using RTs effect values (Figure 4A),
and the second when genes were ranked based on Rank-
Spec effect specificity values (Figure 4B).
As noted above, the RTs index characterizes the level
of the knockout effect on a given structure s, but it does
not reflect the specificity of the effect to this structure,
that is, a ratio of the effect on structure of s to the effect
on other structures. Whereas RankSpec index charac-
terizes specificity. Surprisingly for us, it turned out that
the hierarchical clustering trees for these two indicators
have a very similar appearance. At the same time, as can
be seen from Figure 4, the brain structures are divided
into three groups based on hierarchical clustering: the
cortex (the cluster is shown in green), the subcortical
structures (shown in red), and the cerebellum. This divi-
sion partly corresponds to the natural morphological
division.
However, it should be noted that the direct distance
values were higher in the RankSpec clustering, which
suggests that the top-100 lists of genes ranked by Rank-
Spec value contain more genes that are specific to only
one of the brain structures.
Comparison of model predictions with experimental data
For the validation of the models, we compared the
predictions of the effect of suppressing the expression
of target genes on the expression of objective genes
from the “apoptotic process” GO category with
experimental data. From the work of Ovcharenko et
al. [33], we took a list of genes, siRNA-inhibition of
which was found to lead to a significant activation of
caspase-3.
Figure 3 Spatial distribution of the NR3C1 (A) and Foxa2 (B) genes knockout effects RTp . Three orthogonal maximum intensity projections
are presented. The darker regions correspond to higher RTp values. It can be seen that the effect is concentrated mainly in the cerebellum (A)
and pons (B).
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In [33] 34 genes were found to be linked to activation
of caspase-3. A total of 30 of these genes turned out to
be among analysed target genes. Four remaining genes
had no direct links with the genes from the “apoptotic
process” GO category for either STRING or ANDSys-
tem networks therefore they remained untested by our
method.
We assumed that in the case of adequate constructed
models, predicted effect on gene expression of “apopto-
tic process” GO category for the knockouts of the 30
experimentally discovered genes should exceed the aver-
age effect predicted for the knockouts of other target
genes, for which the experiment showed no significant
activation of caspase-3. Since no tissue-specific effect
can be assigned to experiments provided in [33], we
considered whole brain average value RTall as a modelled
knockout effect for comparison.
Comparison of distributions of values of the knockout
effect of 30 genes from [33] and the whole set of 6,133
genes from STRING and 3,880 genes from ANDSystem
using Mann-Whitney criterion showed a statistically sig-
nificant (p <0.001) difference between distributions. In
this analysis we considered STRING and regulatory
ANDSystem network separately and the results was sig-
nificant for both networks.
The average value of the predicted knockout effect
RTall for the 30 experimentally found genes was 4.5 and
4.4, while the average of all target genes was 0.93 and
0.86 for the STRING and ANDSystem, respectively.
Additionally, a similar analysis was performed on data
on siRNA-inhibition in glioma cell lines. To do this a
list of genes was taken from the work of [34]. The list
consisted of 55 genes identified in siRNA screening, that
significantly induced cell death in T98G glioma cells
upon downregulation of these genes. Of these 55 genes
we have considered 34 as target genes for the STRING
network-based models and 17 genes for ANDSystem-
based models. For the rest of the genes there were no
direct links with the genes from the “apoptotic process”
GO category. Comparison of distributions of predicted
knockout effect values of genes from experimental work
[34] and the whole set of analysed target genes showed
a statistically significant difference between them (p
<0.001 for the STRING network and p <0.01 for
ANDSystem regulatory network, Mann-Whitney criter-
ion was used). The mean values of the predicted effect
Figure 4 Hierarchical clustering of brain structures based on similarity of the top 100 genes lists. Lists of genes were ranked by knockout
effect on the expression of objective genes RTs (A) and by RankSpec values (B)
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value RTall for the experimentally discovered genes were
3.88 and 0.98 while the average values of all target
genes were 0.93 and 0.86 for the STRING and ANDSys-
tem, respectively.
Thus, the results confirm the predictive power of our
model presenting statistically higher than average values
of predicted knockout effect on apoptosis for genes that
have been experimentally proved to have a high impact
on the system when being siRNA-inhibited. However, it
should be kept in mind that the comparison was carried
out with the results for siRNA-inhibition. In the future
we plan to expand the validation of the method and of
the produced models on the effects of various factors
such as small chemical compounds, genetic variations,
and others. Such studies are necessary in order to deter-
mine the applicability of the models in the design of
medical products.
GO biological processes enrichment analysis of the top
target genes
For detection of biological processes that involve target
genes, knockout of which leads to the most severe effect
on the expression of genes from GO category “apoptotic
process”, the GO biological processes enrichment analy-
sis was performed (Additional file 1). The analysis was
conducted for the top 100 genes that have the strongest
effect averaged over all spatial areas of the brain.
Among the top ten GO categories overrepresented for
genes from the String network, GO biological processes
associated with the response to stimuli, immune pro-
cesses, viral processes, and multi-organism processes
were found. For genes from the ANDSystem regulatory
network among ten most overrepresented GO biological
processes categories were present related to the regula-
tion of metabolic processes, cell proliferation and cell
death, response to different stimuli and stress.
To test whether the genes involved in the identified
overrepresented biological processes are functionally
related to each other, for each overrepresented GO cate-
gory gene networks including genes from this category
as vertices were compared with networks built on ran-
dom gene sets (see Materials and methods). We
assumed that the more functionally connected genes
have the greater number of interactions between them.
The functional connectivity calculated by this method
was used to re-rank significantly overrepresented GO
biological processes.
After re-ranking of GO categories overrepresented for
genes from the String network the list of top 10 GO
categories was completely changed and included cate-
gories related to response to growth factors, signaling
pathways, response to injury and other. For genes from
the ANDSystem regulatory network, the list of top
10 overrepresented GO categories has not changed after
re-ranking. This suggests that genes included in the top
10 overrepresented GO categories are strongly related
and function in a common biological process. However,
among the top 50 overrepresented GO categories, biolo-
gical processes related to phosphorylation received low
ranks according to the criterion of the functional
connectivity. For example, the category «positive regula-
tion of phosphorylation» ranked 11th according to
Bingo and ranked 328th after re-ranking by functional
connectivity.
Since the initial focus of our research was on the
genes from “apoptotic process” GO category, taken as
objective genes, the resulting list of target genes can be
enriched with genes from the same GO category. There-
fore, we have conducted an additional analysis of GO
biological processes enrichment for top-100 genes with
the highest RTall values, which do not belong to the
“apoptotic process” GO category (Additional file 2). The
results for the genes found with the STRING network
showed that among the top 10 overrepresented cate-
gories some remained the same as in the results without
exclusion of apoptosis-related genes. Those categories
include related to response to stimuli, and to immune
processes. The new categories appeared in the top 10
categories were related to regulation of cellular process.
For genes found with the ANDSystem network some
differences were also observed among the top 10 overre-
presented categories. New categories related to positive
regulation of transcription and regulation of multicellu-
lar organismal process were added, whereas cell prolif-
eration and cell death, response to different stimuli and
stress were not included in the list of top 10 categories
after the exclusion of apoptosis-related genes.
It is likely that knockout of genes involved in overrepre-
sented GO biological processes found in the analysis will
also have an effect on apoptosis. Therefore, these pro-
cesses can be taken into account in the evaluation of side
effects that may occur after the knockout of target genes.
Overlap between potential target genes and known
pharmacological targets
We were interested in identifying potential target genes
used as targets for known drugs. Our analysis showed
that the DrugBank database contains information on
more than 1,700 known pharmacological targets among
the 7,540 analysed target genes.
Furthermore, it was found that the ratio of known
pharmacological targets among potential target genes
increases with the magnitude of the knockout effect
RTall (Figure 5). Figure 5 also shows that the highest and
the lowest proportions of the known pharmacological
targets fall onto the tails of the knockout effect
distribution.
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Unfortunately, the DrugBank database did not contain
data that describes a direct relationship between pharmaco-
logical targets and diseases. However, for some of the tar-
gets the database contained data about drugs acting on
these targets. To find out what diseases correspond to iden-
tified pharmacological targets, we conducted a search for
the links between drugs and diseases in the KEGG database.
Thus, we were able to link 204 known pharmacological tar-
gets with 112 diseases. For the rest 1,513 pharmacological
targets there was no such information in KEGG.
Analysis of target genes for different drugs showed that
targets of drugs against different kinds of diseases have
different distributions of the predicted knockout effect
on apoptosis genes. All the target genes could be divided
into three groups (Figure 6): targets of genes of drugs
against immune system diseases (52 genes, Figure 6A),
against cancer (36 genes, Figure 6B) and against other
diseases (Figure 6C). The first two groups contained 43%
of all known targets with identified diseases. For the first
two groups, the distribution of corresponding knockout
effect ranks shows that most of the target genes have
higher values of effect on objective genes from the GO
category “apoptotic process”, whereas the same distribu-
tion for targets of drugs against other diseases (group 3,
Figure 6C) shows that most of the genes have lower
effects on apoptosis.
Especially important today is the study of neurodegenera-
tive diseases. Among the potential target genes 29 turned
out to be known pharmacological targets for drugs against
diseases of the nervous system, including Alzheimer’s
disease. The targets for drugs against Alzheimer’s disease
included genes of nicotinic acetylcholine receptors
(CHRNB3, CHRNE, CHRNB1, CHRND).
It is known that nicotinic acetylcholine receptors
(nAChRs) play major role in the cognitive function of the
brain involved in memory and sensory information pro-
cessing [59-61]. Functional changes, violation of biogen-
esis and transport of nAChRs are important components
of Alzheimer’s disease [62]. nAChRs are promising tar-
geted drugs against neurodegenerative diseases [61].
Thus, cholinergic receptor, nicotinic, beta 3 (neuronal)
(CHRNB3) is the target of galantamine, a drug used in
Alzheimer’s disease [63,64]. Galantamine has a dual
action on the cholinergic system: it inhibits acetylcholi-
nesterase (AChE) and allosterically modulates the activity
of nicotinic receptors (nAChRs) [64-66]. Binding of
galantamine with acetylcholinesterase in the brain
Figure 5 Dependence of the ratio of the known
pharmacological targets among potential target genes on the
knockout effect value RTall . Black line shows the ratio of known
targets, blue histogram displays the distribution of the knockout
effect values RTall . Presented are results for STRING gene network.
Presented ratio approaches 1.0 at the right tail of the distribution
corresponding to a small proportion of genes with the highest
predicted knockout effect values.
Figure 6 Distribution of the knockout effects of known drug targets. The known drug target genes are grouped by the nature of diseases
the drugs are intended for: immune system diseases (A), cancer (B) and other diseases (C).
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reduces acetylcholine (ACh) catabolism, which provides
an increase in the level of acetylcholine (ACh) in the
synaptic cleft. In addition to inhibition of AChE,
galanthamine modulates nicotinic acetylcholine neuro-
transmission through allosteric potentiation of the pre-
and postsynaptic nAChR [64,67,68]. Since presynaptic
nAChRs may mediate the release of acetylcholine, the
allosteric modulation of these receptors may increase the
yield of acetylcholine and other neurotransmitters, such as
glutamate and dopamine, which plays an important role in
ensuring normal functioning of the brain [64,69,70].
Knockout of these genes had the greatest predicted
effect on expression of gene involved in the GO category
“apoptotic process”, according to the RankSpec indicator,
in brain regions such as the thalamus and pons for
CHRNB3 and CHRNE genes, respectively. Knockout of
CHRNB1 and CHRND genes had the greatest effect in
the parietal lobe. It is known that nAChRs are widely
represented in the thalamus, which is involved in the
functioning of the limbic system which is, among other
functions, responsible for normal memory functions
[71,72]. In this regard, the impact of drugs, including
galantamine, on nAChRs, has a positive effect on cogni-
tive functions and provides a therapeutic effect in the
treatment of Alzheimer’s disease [63,64,71]. Our results
are also consistent with recent studies of the role of the
parietal lobe in the development of Alzheimer’s disease
[73,74]. At the moment, in the early stages of Alzheimer’s
disease structural, functional and metabolic changes are
observed in the parietal lobe [73], including observed
changes in the expression patterns of nAChRs [74].
Conclusion
The study of tissue-specific gene knockout effect on var-
ious biological processes is an important task in drug
development. The approach presented in this paper is
based on statistical models and allows to predict the
effect of changes in the expression of target genes on the
expression of a list of objective genes, related to a given
biological processes. With the use of this method an eva-
luation was conducted of the effect of gene knockout on
expression of genes related to “apoptotic process” GO
category in various brain structures.
The proposed method showed good agreement with
the experimental data [33,34]. It was shown that the
knockout of 30 genes taken from [33] and 55 genes
taken from [34] had significantly stronger impact in the
comparison with the rest of the target genes, which did
not show a significant effect in the experiment.
Analysis of the models showed that for the 15% of target
genes a pronounced structure-specific effect was observed
on the expression of objective genes involved in the GO
category “apoptotic process”, for a variety of anatomical
structures of the brain. Thus, our models may be useful
for the search of target genes that provide the effect of
drugs aimed at predetermined areas of the brain. Further
we are planning to look for experimental confirmations of
the findings of our theoretical work.
Among the 7,540 analysed target genes, 23% appeared
to be known pharmacological targets. Analysis of the
knockout effects of genes corresponding to these targets
showed that these genes could be divided into three
groups: a group of genes that are targets for drugs against
cancer; a group of target genes for drugs against immune
diseases and a group of target genes against other dis-
eases. Most of the genes from the first and second groups
showed strong predicted knockout effect on expression
of genes from the GO “apoptotic process”. In the third
group, however, the largest number of genes had weakly
expressed knockout effect according to our model.
Among the analysed target genes, nicotinic acetylcho-
line receptors (CHRNB3, CHRNE, CHRNB1, CHRND)
were found, which are targets of drugs against Alzhei-
mer’s disease. Models for CHRNB1 and CHRND genes
showed that their knockout would have the most pro-
nounced effect on expression of apoptosis genes in the
parietal lobe of the brain, and for gene CHRNB3,
CHRNE in thalamus and pons, respectively.
Thus, the proposed approach can be used to examine
the tissue-specific molecular mechanisms of drug action
on known pharmacological targets, and also to identify
new potential drug targets, specifically acting on prede-
termined areas of the brain. The developed method can
also be applied to a wide range of problems associated
with the study of the functioning of molecular genetic
systems in different structures of the brain.
It should also be added that the method can be easily
implemented and expanded to different objective gene sys-
tems to assess knockout effects. The method can also be
easily modified to make use of different sources of expres-
sion data providing a wide range of further applications.
Other models of machine learning can also be used in this
method (neural networks, support-vector machines with
different kernels, etc.) which would expand the range of
modeled regulatory interactions. Further we plan to explore
these options in order to advance the proposed method.
Thus, we developed a method of creating target-cen-
tric statistical models that can be potentially used for a
wide range of tasks associated with the prediction of tis-
sue-specific effects of various factors on gene expression,
including the search for tissue-specific drug targets.
Additional material
Additional file 1: GO biological processes enrichment analysis
results on top 100 target genes. The analysis was conducted for the
top 100 genes that have the strongest effect averaged over all spatial
areas of the brain.
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Additional file 2: GO biological processes enrichment analysis
results on top 100 target genes not included in the list of
apoptotic genes. The analysis was conducted for the top 100 genes
that have the strongest effect averaged over all spatial areas of the brain,
which do not belong to the “apoptotic process” GO category.
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